Gregory A. Light - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 
Area:
schizophrenia, MMN, PPI, P50
Website:
http://psychiatry.ucsd.edu/faculty/GLight.html

130 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tanaka-Koshiyama K, Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Sprock J, Braff DL, Light GA. Abnormal Spontaneous Gamma Power Is Associated With Verbal Learning and Memory Dysfunction in Schizophrenia. Frontiers in Psychiatry. 11: 832. PMID 33110410 DOI: 10.3389/fpsyt.2020.00832  0.88
2020 Swerdlow NR, Bhakta S, Talledo J, Kotz J, Roberts BZ, Clifford RE, Thomas M, Joshi Y, Molina JL, Light GA. Memantine effects on auditory discrimination and training in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32961542 DOI: 10.1038/s41386-020-00865-8  0.48
2020 Koshiyama D, Thomas ML, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia. Schizophrenia Bulletin. PMID 32856089 DOI: 10.1093/schbul/sbaa116  0.88
2020 Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. Abnormal Effective Connectivity Underlying Auditory Mismatch Negativity Impairments in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32830097 DOI: 10.1016/j.bpsc.2020.05.011  0.88
2020 Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. A distributed frontotemporal network underlies gamma-band synchronization impairments in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32829382 DOI: 10.1038/s41386-020-00806-5  0.88
2020 Treichler EBH, Cardoso L, Du Y, Nungaray J, Hochberger WC, Joshi YB, Sprock J, Cohen AN, Light GA. Contextualizing the road to recovery: A novel method of assessing outcome trajectories in clinical trials. Psychological Services. PMID 32658511 DOI: 10.1037/ser0000432  0.52
2020 Lee J, Green MF, Nuechterlein KH, Swerdlow NR, Greenwood TA, Hellemann GS, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study. Plos One. 15: e0232855. PMID 32401791 DOI: 10.1371/journal.pone.0232855  0.88
2020 Molina JL, Voytek B, Thomas ML, Joshi YB, Bhakta SG, Talledo JA, Swerdlow NR, Light GA. Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32340927 DOI: 10.1016/j.bpsc.2020.02.004  0.52
2019 Hochberger WC, Thomas ML, Joshi YB, Molina J, Treichler EBH, Nungaray J, Cardoso L, Sprock J, Swerdlow N, Light GA. Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients. Schizophrenia Research. PMID 31759809 DOI: 10.1016/j.schres.2019.11.015  0.52
2019 Greenwood TA, Lazzeroni LC, Maihofer AX, Swerdlow NR, Calkins ME, Freedman R, Green MF, Light GA, Nievergelt CM, Nuechterlein KH, Radant AD, Siever LJ, Silverman JM, Stone WS, Sugar CA, et al. Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study. Jama Psychiatry. PMID 31596458 DOI: 10.1001/jamapsychiatry.2019.2850  0.88
2019 Light GA, Swerdlow NR. Selection criteria for neurophysiologic biomarkers to accelerate the pace of CNS therapeutic development. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31506611 DOI: 10.1038/s41386-019-0519-0  0.48
2019 Swerdlow NR, Bhakta SG, Talledo J, Benster L, Kotz J, Lavadia M, Light GA. Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31445502 DOI: 10.1038/s41386-019-0495-4  0.48
2019 Perez VB, Miyakoshi M, Makeig SD, Light GA. Mismatch negativity reveals plasticity in cortical dynamics after 1-hour of auditory training exercises. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. PMID 31176741 DOI: 10.1016/j.ijpsycho.2019.06.003  0.48
2019 Lainscsek C, Sampson AL, Kim R, Thomas ML, Man K, Lainscsek X, Swerdlow NR, Braff DL, Sejnowski TJ, Light GA. Nonlinear dynamics underlying sensory processing dysfunction in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 116: 3847-3852. PMID 30808768 DOI: 10.1073/pnas.1810572116  0.88
2019 Joshi YB, Thomas ML, Hochberger WC, Bismark AW, Treichler EBH, Molina J, Nungaray J, Cardoso L, Sprock J, Swerdlow NR, Light GA. Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients. Schizophrenia Research. PMID 30738698 DOI: 10.1016/j.schres.2019.01.016  0.52
2019 Treichler EBH, Thomas ML, Bismark AW, Hochberger WC, Tarasenko M, Nungaray J, Cardoso L, Joshi YB, Zhang W, Sprock J, Swerdlow N, Cohen AN, Light GA. Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia. Schizophrenia Research. PMID 30660574 DOI: 10.1016/j.schres.2018.12.034  0.52
2018 Joshi YB, Light GA. Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in Schizophrenia. Frontiers in Psychiatry. 9: 554. PMID 30510520 DOI: 10.3389/fpsyt.2018.00554  0.52
2018 Hochberger WC, Joshi YB, Thomas ML, Zhang W, Bismark AW, Treichler EBH, Tarasenko M, Nungaray J, Sprock J, Cardoso L, Swerdlow N, Light GA. Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30377381 DOI: 10.1038/s41386-018-0256-9  0.52
2018 Thomas ML, Bismark AW, Joshi YB, Tarasenko M, Treichler EBH, Hochberger WC, Zhang W, Nungaray J, Sprock J, Cardoso L, Tiernan K, Attarha M, Braff DL, Vinogradov S, Swerdlow N, ... Light GA, et al. Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care. Schizophrenia Research. PMID 30055883 DOI: 10.1016/j.schres.2018.07.025  0.88
2018 Thomas ML, Treichler EBH, Bismark A, Shiluk AL, Tarasenko M, Zhang W, Joshi YB, Sprock J, Cardoso L, Tiernan K, Light GA. Computerized cognitive training is associated with improved psychosocial treatment engagement in schizophrenia. Schizophrenia Research. PMID 29929773 DOI: 10.1016/j.schres.2018.06.024  0.52
2018 Bismark AW, Thomas ML, Tarasenko M, Shiluk AL, Rackelmann SY, Young JW, Light GA. Reverse translated and gold standard continuous performance tests predict global cognitive performance in schizophrenia. Translational Psychiatry. 8: 80. PMID 29643355 DOI: 10.1038/s41398-018-0127-5  0.48
2018 Swerdlow NR, Bhakta SG, Light GA. Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge. Schizophrenia Research. PMID 29627173 DOI: 10.1016/j.schres.2018.03.037  0.48
2018 Swerdlow NR, Light GA. Sensorimotor gating deficits in schizophrenia: Advancing our understanding of the phenotype, its neural circuitry and genetic substrates. Schizophrenia Research. PMID 29525460 DOI: 10.1016/j.schres.2018.02.042  0.48
2017 Swerdlow NR, Bhakta SG, Talledo JA, Franz DM, Hughes EL, Rana BK, Light GA. Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29154367 DOI: 10.1038/npp.2017.285  0.48
2017 Bhakta SG, Light GA, Talledo JA, Balvaneda B, Hughes E, Alvarez A, Rana BK, Young JW, Swerdlow NR. Tolcapone-enhanced neurocognition in healthy adults: neural basis and predictors. The International Journal of Neuropsychopharmacology. PMID 29020372 DOI: 10.1093/ijnp/pyx074  0.48
2017 Joshi YB, Breitenstein B, Tarasenko M, Thomas ML, Chang WL, Sprock J, Sharp RF, Light GA. Mismatch negativity impairment is associated with deficits in identifying real-world environmental sounds in schizophrenia. Schizophrenia Research. PMID 28927552 DOI: 10.1016/j.schres.2017.05.020  0.52
2017 Bismark AW, Thomas ML, Tarasenko M, Shiluk AL, Rackelmann SY, Young JW, Light GA. Relationship between effortful motivation and neurocognition in schizophrenia. Schizophrenia Research. PMID 28673753 DOI: 10.1016/j.schres.2017.06.042  0.48
2017 Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension. Schizophrenia Research. PMID 28549722 DOI: 10.1016/j.schres.2017.05.013  0.88
2017 Light GA, Zhang W, Joshi YB, Bhakta S, Talledo JA, Swerdlow NR. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28425497 DOI: 10.1038/npp.2017.81  0.52
2017 Thomas ML, Patt VM, Bismark A, Sprock J, Tarasenko M, Light GA, Brown GG. Evidence of Systematic Attenuation in the Measurement of Cognitive Deficits in Schizophrenia. Journal of Abnormal Psychology. PMID 28277736 DOI: 10.1037/abn0000256  0.48
2017 Perez VB, Tarasenko M, Miyakoshi M, Pianka ST, Makeig SD, Braff DL, Swerdlow NR, Light GA. Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28139679 DOI: 10.1038/npp.2017.25  0.88
2016 Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, ... ... Light GA, et al. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. Jama Psychiatry. PMID 27926742 DOI: 10.1001/jamapsychiatry.2016.2980  0.88
2016 Young JW, Bismark AW, Sun Y, Zhang W, McIlwain M, Grootendorst I, Light GA. Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated Task. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27917869 DOI: 10.1038/npp.2016.268  0.44
2016 Swerdlow NR, Tarasenko M, Bhakta SG, Talledo J, Alvarez AI, Hughes EL, Rana B, Vinogradov S, Light GA. Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients. Schizophrenia Bulletin. PMID 27798224 DOI: 10.1093/schbul/sbw148  0.48
2016 Swerdlow NR, Light GA. Animal Models of Deficient Sensorimotor Gating in Schizophrenia: Are They Still Relevant? Current Topics in Behavioral Neurosciences. PMID 27311762 DOI: 10.1007/7854_2015_5012  0.48
2016 Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, et al. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophrenia Research. PMID 27132484 DOI: 10.1016/j.schres.2016.04.011  0.88
2016 Bhakta SG, Chou HH, Rana B, Talledo JA, Balvaneda B, Gaddis L, Light GA, Swerdlow NR. Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy. Psychopharmacology. PMID 27076209 DOI: 10.1007/s00213-016-4291-0  0.88
2016 Tarasenko M, Perez VB, Pianka ST, Vinogradov S, Braff DL, Swerdlow NR, Light GA. Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophrenia. Schizophrenia Research. PMID 26851143 DOI: 10.1016/j.schres.2016.01.019  0.88
2015 Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, et al. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophrenia Research. PMID 26597662 DOI: 10.1016/j.schres.2015.11.008  0.88
2015 Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, et al. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History. The American Journal of Psychiatry. appiajp201515050605. PMID 26441157 DOI: 10.1176/appi.ajp.2015.15050605  0.88
2015 Light GA, Swerdlow NR. Bending the curve on psychosis outcomes. The Lancet. Psychiatry. 2: 365-7. PMID 26360262 DOI: 10.1016/S2215-0366(15)00172-8  0.88
2015 Swerdlow NR, Bhakta S, Chou HH, Talledo JA, Balvaneda B, Light GA. Memantine Effects on Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26062785 DOI: 10.1038/npp.2015.162  0.48
2015 Light GA, Swerdlow NR. Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia. Annals of the New York Academy of Sciences. 1344: 105-19. PMID 25752648 DOI: 10.1111/nyas.12730  0.88
2015 Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 38-46. PMID 25749017 DOI: 10.1016/j.schres.2015.01.017  0.88
2015 Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, et al. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophrenia Research. 163: 73-9. PMID 25682549 DOI: 10.1016/j.schres.2015.01.027  0.88
2015 Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, et al. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophrenia Research. 163: 47-52. PMID 25553977 DOI: 10.1016/j.schres.2014.12.016  0.88
2015 Light GA, Makeig S. Electroencephalographic biomarkers of psychosis: present and future. Biological Psychiatry. 77: 87-9. PMID 25524305 DOI: 10.1016/j.biopsych.2014.11.002  0.88
2015 Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, et al. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 32-7. PMID 25497440 DOI: 10.1016/j.schres.2014.10.029  0.88
2015 Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, et al. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophrenia Research. 163: 63-72. PMID 25449710 DOI: 10.1016/j.schres.2014.09.042  0.88
2015 Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophrenia Research. 163: 17-23. PMID 25432636 DOI: 10.1016/j.schres.2014.10.049  0.88
2015 Turetsky BI, Dress EM, Braff DL, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, ... ... Light G, et al. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2. Schizophrenia Research. 163: 53-62. PMID 25306203 DOI: 10.1016/j.schres.2014.09.024  0.88
2015 Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, et al. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications. Schizophrenia Research. 163: 24-31. PMID 25248939 DOI: 10.1016/j.schres.2014.08.014  0.88
2014 Rissling AJ, Miyakoshi M, Sugar CA, Braff DL, Makeig S, Light GA. Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia. Neuroimage. Clinical. 6: 424-37. PMID 25379456 DOI: 10.1016/j.nicl.2014.09.006  0.88
2014 Tarasenko MA, Swerdlow NR, Makeig S, Braff DL, Light GA. The auditory brain-stem response to complex sounds: a potential biomarker for guiding treatment of psychosis. Frontiers in Psychiatry. 5: 142. PMID 25352811 DOI: 10.3389/fpsyt.2014.00142  0.88
2014 Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, et al. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings. Psychiatry Research. 219: 67-71. PMID 24913833 DOI: 10.1016/j.psychres.2014.05.035  0.88
2014 Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophrenia Bulletin. 40: 1404-11. PMID 24903414 DOI: 10.1093/schbul/sbu064  0.88
2014 Light GA, Swerdlow NR. Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle. Current Topics in Behavioral Neurosciences. 21: 293-314. PMID 24850080 DOI: 10.1007/7854_2014_316  0.88
2014 Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, et al. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? Plos One. 9: e88379. PMID 24523888 DOI: 10.1371/journal.pone.0088379  0.44
2014 Swerdlow NR, Light GA, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Ray A, Seidman LJ, Siever LJ, Silverman JM, et al. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophrenia Research. 152: 503-12. PMID 24405980 DOI: 10.1016/j.schres.2013.12.004  0.88
2014 Perez VB, Swerdlow NR, Braff DL, Näätänen R, Light GA. Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses. Biomarkers in Medicine. 8: 9-14. PMID 24325220 DOI: 10.2217/bmm.13.133  0.88
2013 Swerdlow NR, Light GA, Trim RS, Breier MR, Hines SR, Powell SB. Forebrain gene expression predicts deficits in sensorimotor gating after isolation rearing in male rats. Behavioural Brain Research. 257: 118-28. PMID 24076151 DOI: 10.1016/j.bbr.2013.09.005  0.48
2013 Light GA, Näätänen R. Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders. Proceedings of the National Academy of Sciences of the United States of America. 110: 15175-6. PMID 23995447 DOI: 10.1073/pnas.1313287110  0.88
2013 Swerdlow NR, Powell SB, Breier MR, Hines SR, Light GA. Coupling of gene expression in medial prefrontal cortex and nucleus accumbens after neonatal ventral hippocampal lesions accompanies deficits in sensorimotor gating and auditory processing in rats. Neuropharmacology. 75: 38-46. PMID 23810830 DOI: 10.1016/j.neuropharm.2013.06.003  0.48
2013 Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, ... ... Light GA, et al. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 170: 521-32. PMID 23511790 DOI: 10.1176/appi.ajp.2012.12020186  0.88
2013 Rissling AJ, Park SH, Young JW, Rissling MB, Sugar CA, Sprock J, Mathias DJ, Pela M, Sharp RF, Braff DL, Light GA. Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls. Schizophrenia Research. 146: 326-35. PMID 23490760 DOI: 10.1016/j.schres.2013.01.035  0.88
2013 Calkins ME, Ray A, Gur RC, Freedman R, Green MF, Greenwood TA, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar C, et al. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biological Psychiatry. 73: 976-84. PMID 23395246 DOI: 10.1016/j.biopsych.2012.12.021  0.88
2013 Takahashi H, Rissling AJ, Pascual-Marqui R, Kirihara K, Pela M, Sprock J, Braff DL, Light GA. Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses. Neuroimage. 66: 594-603. PMID 23085112 DOI: 10.1016/j.neuroimage.2012.09.074  0.88
2012 Light GA, Swerdlow NR, Rissling AJ, Radant A, Sugar CA, Sprock J, Pela M, Geyer MA, Braff DL. Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. Plos One. 7: e39434. PMID 22802938 DOI: 10.1371/journal.pone.0039434  0.88
2012 Swerdlow NR, Shilling PD, Breier M, Trim RS, Light GA, Marie RS. Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats. Psychopharmacology. 224: 349-62. PMID 22700037 DOI: 10.1007/s00213-012-2758-1  0.48
2012 Rissling AJ, Braff DL, Swerdlow NR, Hellemann G, Rassovsky Y, Sprock J, Pela M, Light GA. Disentangling early sensory information processing deficits in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 123: 1942-9. PMID 22608970 DOI: 10.1016/j.clinph.2012.02.079  0.88
2012 Swerdlow NR, Light GA, Breier MR, Shoemaker JM, Saint Marie RL, Neary AC, Geyer MA, Stevens KE, Powell SB. Sensory and sensorimotor gating deficits after neonatal ventral hippocampal lesions in rats. Developmental Neuroscience. 34: 240-9. PMID 22572564 DOI: 10.1159/000336841  0.48
2012 Kirihara K, Rissling AJ, Swerdlow NR, Braff DL, Light GA. Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia. Biological Psychiatry. 71: 873-80. PMID 22361076 DOI: 10.1016/j.biopsych.2012.01.016  0.88
2012 Greenwood TA, Light GA, Swerdlow NR, Radant AD, Braff DL. Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. Plos One. 7: e29630. PMID 22253750 DOI: 10.1371/journal.pone.0029630  0.88
2012 Jahshan C, Cadenhead KS, Rissling AJ, Kirihara K, Braff DL, Light GA. Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychological Medicine. 42: 85-97. PMID 21740622 DOI: 10.1017/S0033291711001061  0.88
2011 Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, et al. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 128: 102-10. PMID 21288694 DOI: 10.1016/j.schres.2011.01.005  0.88
2010 Rissling AJ, Makeig S, Braff DL, Light GA. Neurophysiologic markers of abnormal brain activity in schizophrenia. Current Psychiatry Reports. 12: 572-8. PMID 20857348 DOI: 10.1007/s11920-010-0149-z  0.88
2010 Williams LE, Light GA, Braff DL, Ramachandran VS. Reduced multisensory integration in patients with schizophrenia on a target detection task. Neuropsychologia. 48: 3128-36. PMID 20600181 DOI: 10.1016/j.neuropsychologia.2010.06.028  0.88
2010 Light GA, Williams LE, Minow F, Sprock J, Rissling A, Sharp R, Swerdlow NR, Braff DL. Electroencephalography (EEG) and event-related potentials (ERPs) with human participants. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 6.25.1-24. PMID 20578033 DOI: 10.1002/0471142301.ns0625s52  0.88
2010 Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, et al. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophrenia Research. 119: 175-82. PMID 20382002 DOI: 10.1016/j.schres.2010.03.004  0.88
2010 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, et al. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 47: 846-56. PMID 20374545 DOI: 10.1111/j.1469-8986.2010.01004.x  0.88
2010 Breier MR, Lewis B, Shoemaker JM, Light GA, Swerdlow NR. Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats. Behavioural Brain Research. 208: 560-5. PMID 20080128 DOI: 10.1016/j.bbr.2009.12.037  0.88
2010 Williams LE, Ramachandran VS, Hubbard EM, Braff DL, Light GA. Superior size-weight illusion performance in patients with schizophrenia: evidence for deficits in forward models. Schizophrenia Research. 121: 101-6. PMID 19931421 DOI: 10.1016/j.schres.2009.10.021  0.88
2009 Kiang M, Braff DL, Sprock J, Light GA. The relationship between preattentive sensory processing deficits and age in schizophrenia patients. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 120: 1949-57. PMID 19786365 DOI: 10.1016/j.clinph.2009.08.019  0.88
2009 Young JW, Light GA, Marston HM, Sharp R, Geyer MA. The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. Plos One. 4: e4227. PMID 19156216 DOI: 10.1371/journal.pone.0004227  0.88
2008 Turetsky BI, Greenwood TA, Olincy A, Radant AD, Braff DL, Cadenhead KS, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Schork NJ, et al. Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biological Psychiatry. 64: 1051-9. PMID 18701089 DOI: 10.1016/j.biopsych.2008.06.018  0.88
2008 Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology. 199: 331-88. PMID 18568339 DOI: 10.1007/s00213-008-1072-4  0.88
2008 Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ. Advances in endophenotyping schizophrenia. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 7: 11-8. PMID 18458787  0.88
2008 Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, et al. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 103: 218-28. PMID 18406578 DOI: 10.1016/j.schres.2008.02.014  0.88
2008 Kiang M, Kutas M, Light GA, Braff DL. An event-related brain potential study of direct and indirect semantic priming in schizophrenia. The American Journal of Psychiatry. 165: 74-81. PMID 18056222 DOI: 10.1176/appi.ajp.2007.07050763  0.88
2008 Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ, Calkins ME, Gur RE, Gur RC, Turetsky BI, Dobie DJ, Radant AD, Tsuang DW, Freedman R, Olincy A, Cadenhead KS, et al. Advances in endophenotyping schizophrenia World Psychiatry. 7: 11-18.  0.88
2007 Light GA, Swerdlow NR, Braff DL. Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. Journal of Cognitive Neuroscience. 19: 1624-32. PMID 18271737 DOI: 10.1162/jocn.2007.19.10.1624  0.88
2007 Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Archives of General Psychiatry. 64: 1242-50. PMID 17984393 DOI: 10.1001/archpsyc.64.11.1242  0.88
2007 Möller B, Light GA, Fitzgerald PB, Snyder JS, Chen R, Daskalakis ZJ. Relationship between P50 suppression and the cortical silent period. Neuroreport. 18: 1503-6. PMID 17712283 DOI: 10.1097/WNR.0b013e3282ef6a29  0.88
2007 Wynn JK, Green MF, Sprock J, Light GA, Widmark C, Reist C, Erhart S, Marder SR, Mintz J, Braff DL. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophrenia Research. 95: 134-42. PMID 17662577 DOI: 10.1016/j.schres.2007.05.039  0.88
2007 Kiang M, Light GA, Prugh J, Coulson S, Braff DL, Kutas M. Cognitive, neurophysiological, and functional correlates of proverb interpretation abnormalities in schizophrenia. Journal of the International Neuropsychological Society : Jins. 13: 653-63. PMID 17521483 DOI: 10.1017/S1355617707070816  0.88
2007 Kiang M, Kutas M, Light GA, Braff DL. Electrophysiological insights into conceptual disorganization in schizophrenia. Schizophrenia Research. 92: 225-36. PMID 17383161 DOI: 10.1016/j.schres.2007.02.001  0.88
2007 Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, et al. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 92: 237-51. PMID 17346930 DOI: 10.1016/j.schres.2007.01.012  0.88
2007 Braff DL, Light GA, Swerdlow NR. Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients. Biological Psychiatry. 61: 1204-7. PMID 17161386 DOI: 10.1016/j.biopsych.2006.08.015  0.88
2007 Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophrenia Bulletin. 33: 69-94. PMID 17135482 DOI: 10.1093/schbul/sbl060  0.88
2007 Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, et al. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophrenia Bulletin. 33: 33-48. PMID 17035358 DOI: 10.1093/schbul/sbl044  0.88
2007 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, et al. Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophrenia Research. 89: 320-9. PMID 17023145 DOI: 10.1016/j.schres.2006.08.010  0.88
2006 Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Archives of General Psychiatry. 63: 1325-35. PMID 17146007 DOI: 10.1001/archpsyc.63.12.1325  0.88
2006 Light GA, Hsu JL, Hsieh MH, Meyer-Gomes K, Sprock J, Swerdlow NR, Braff DL. Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biological Psychiatry. 60: 1231-40. PMID 16893524 DOI: 10.1016/j.biopsych.2006.03.055  0.88
2006 Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier M, Neary A, Auerbach PP. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 506-15. PMID 16123772 DOI: 10.1038/sj.npp.1300841  0.88
2005 Wynn JK, Light GA, Breitmeyer B, Nuechterlein KH, Green MF. Event-related gamma activity in schizophrenia patients during a visual backward-masking task. The American Journal of Psychiatry. 162: 2330-6. PMID 16330598 DOI: 10.1176/appi.ajp.162.12.2330  0.88
2005 Braff DL, Light GA. The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia. Dialogues in Clinical Neuroscience. 7: 125-35. PMID 16262208  0.88
2005 Light GA, Braff DL. Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia. The American Journal of Psychiatry. 162: 1741-3. PMID 16135637 DOI: 10.1176/appi.ajp.162.9.1741  0.88
2005 Erickson SK, Schwarzkopf SB, Palumbo D, Badgley-Fleeman J, Smirnow AM, Light GA. Efficacy and tolerability of low-dose donepezil in schizophrenia. Clinical Neuropharmacology. 28: 179-84. PMID 16062097 DOI: 10.1097/01.wnf.0000173714.61744.e6  0.88
2005 Cadenhead KS, Light GA, Shafer KM, Braff DL. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biological Psychiatry. 57: 1504-9. PMID 15953486 DOI: 10.1016/j.biopsych.2005.03.003  0.88
2005 Meincke U, Light GA, Geyer MA, Braff DL. On the waveform of the acoustic startle blink in the paradigm of prepulse inhibition - methodological and physiological aspects. Neuropsychobiology. 52: 24-7. PMID 15942260 DOI: 10.1159/000086174  0.88
2005 Braff DL, Light GA, Ellwanger J, Sprock J, Swerdlow NR. Female schizophrenia patients have prepulse inhibition deficits. Biological Psychiatry. 57: 817-20. PMID 15820241 DOI: 10.1016/j.biopsych.2004.12.030  0.88
2005 Swerdlow NR, Stephany NL, Talledo J, Light G, Braff DL, Baeyens D, Auerbach PP. Prepulse inhibition of perceived stimulus intensity: paradigm assessment. Biological Psychology. 69: 133-47. PMID 15804542 DOI: 10.1016/j.biopsycho.2004.07.002  0.88
2005 Light GA, Braff DL. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Archives of General Psychiatry. 62: 127-36. PMID 15699289 DOI: 10.1001/archpsyc.62.2.127  0.88
2004 Braff DL, Light GA. Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology. 174: 75-85. PMID 15118804 DOI: 10.1007/s00213-004-1848-0  0.88
2004 Meincke U, Light GA, Geyer MA, Braff DL, Gouzoulis-Mayfrank E. Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia. Psychiatry Research. 126: 51-61. PMID 15081627 DOI: 10.1016/j.psychres.2004.01.003  0.88
2004 Light GA. Probing cortico-cortical interactions that underlie the multiple sensory, cognitive, and everyday functional deficits in schizophrenia Behavioral and Brain Sciences. 27: 799. DOI: 10.1017/S0140525X04340185  0.88
2003 Green MF, Mintz J, Salveson D, Nuechterlein KH, Breitmeyer B, Light GA, Braff DL. Visual masking as a probe for abnormal gamma range activity in schizophrenia. Biological Psychiatry. 53: 1113-9. PMID 12814862 DOI: 10.1016/S0006-3223(02)01813-9  0.88
2003 Light GA, Braff DL. Sensory gating deficits in schizophrenia: Can we parse the effects of medication, nicotine use, and changes in clinical status Clinical Neuroscience Research. 3: 47-54. DOI: 10.1016/S1566-2772(03)00018-5  0.88
2002 Cadenhead KS, Light GA, Geyer MA, McDowell JE, Braff DL. Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype? The American Journal of Psychiatry. 159: 869-71. PMID 11986147 DOI: 10.1176/appi.ajp.159.5.869  0.88
2001 Light GA, Braff DL. Measuring P50 suppression and prepulse inhibition in a single recording session. The American Journal of Psychiatry. 158: 2066-8. PMID 11729028 DOI: 10.1176/appi.ajp.158.12.2066  0.88
2001 Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophrenia Research. 49: 171-8. PMID 11343875 DOI: 10.1016/S0920-9964(00)00139-0  0.88
2000 Perry W, Light GA, Davis H, Braff DL. Schizophrenia patients demonstrate a dissociation on declarative and non-declarative memory tests. Schizophrenia Research. 46: 167-74. PMID 11120428 DOI: 10.1016/S0920-9964(99)00229-7  0.88
2000 Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. The American Journal of Psychiatry. 157: 767-71. PMID 10784470 DOI: 10.1176/appi.ajp.157.5.767  0.88
2000 Light GA, Braff DL. Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients? Biological Psychiatry. 47: 463-7. PMID 10704957 DOI: 10.1016/S0006-3223(99)00280-2  0.88
2000 Cadenhead KS, Light GA, Geyer MA, Braff DL. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. The American Journal of Psychiatry. 157: 55-9. PMID 10618013 DOI: 10.1176/AJP.157.1.55  0.88
1999 Light GA, Braff DL. Human and animal studies of schizophrenia-related gating deficits. Current Psychiatry Reports. 1: 31-40. PMID 11122903  0.88
1999 Light GA, Malaspina D, Geyer MA, Luber BM, Coleman EA, Sackeim HA, Braff DL. Amphetamine disrupts P50 suppression in normal subjects. Biological Psychiatry. 46: 990-6. PMID 10509182 DOI: 10.1016/S0006-3223(99)00034-7  0.88
1998 Freedman R, Adler LE, Nagamoto HT, Waldo MC, Braff DL, Light GA. Selection of digital filtering parameters and P50 amplitude Biological Psychiatry. 43: 921-922. PMID 9627749 DOI: 10.1016/S0006-3223(98)00119-X  0.88
1998 Light GA, Braff DL. The "incredible shrinking" P50 event-related potential. Biological Psychiatry. 43: 918-20. PMID 9627748 DOI: 10.1016/S0006-3223(98)00118-8  0.88
1998 Silverstein SM, Light G, Palumbo DR. The Sustained Attention Test: A Measure of Attentional Disturbance Computers in Human Behavior. 14: 463-475.  0.88
Show low-probability matches.